Catherine Walsh
The Long-Game Strategist
NextCure's Reverse Merger: A Catalyst for NXTC Shares
NextCure's merger with Avere Therapeutics could position NXTC for growth in the public markets.
General Fusion Set to Become First Publicly Traded Fusion Company: What Investors Should Know
General Fusion is on track to become the first publicly traded fusion company, a significant milesto…
Lime's $1.7 Billion IPO: A Sign of Renewed Market Confidence?
Lime's $1.7 billion IPO highlights a resurgence in market enthusiasm for new public offerings.
2026 Review: Big Tech's Gains vs. International Rivals
US Big Tech saw strong gains in H1 2026, yet international tech stocks outperformed amid a late-June…
OpenPayd's SPAC Merger: A New Chapter for Fintech
OpenPayd's SPAC merger with Titan Acquisition Corp. signals a promising future for fintech. Here's w…
Onex Partners Expands Portfolio with AirSprint Acquisition: Implications for Private Aviation
Onex Partners' acquisition of AirSprint signals growth potential in private aviation and highlights …
Boundless Bio and Serapha Bio Merger: Implications for Biotech Investors
The merger of Boundless Bio and Serapha Bio, backed by a $230M placement, signals growth potential i…
SpaceX Taps Bond Markets Days After Record IPO, Sits on $100.8B Cash Fortress
SpaceX launches senior unsecured notes offering post-IPO while disclosing massive cash reserves. Key…
TTM Technologies Makes Bold Move: Acquires Swiss Technology Group and ILFA GmbH
TTM Technologies expands its portfolio with the acquisition of Swiss Technology Group and ILFA GmbH,…
GSK's $10.6 Billion Bet on Nuvalent: What It Means for the Biotech Sector
GSK's acquisition of Nuvalent for $10.6 billion signifies a strategic move in the precision oncology…
ProLogium's SPAC Merger: A New Frontier in Solid-State Battery Technology
ProLogium's merger with TDAC marks a significant step in solid-state battery innovation within the E…
HPE's $987M H3C Exit: A Calculated Portfolio Trim or Sign of Shifting Priorities?
HP Enterprise divests nearly 14% stake in H3C Technologies for $987M, signaling portfolio optimizati…
Angelini Pharma's $4.1 Billion Acquisition of Catalyst Pharmaceuticals Explained
Angelini Pharma's acquisition of Catalyst Pharmaceuticals for $4.1 billion marks a major strategic m…
TWFG's APIA Acquisition: A Strategic Move in Specialty Insurance
TWFG Insurance's acquisition of APIA marks a significant step in expanding its specialty insurance c…
TSX Composite Dips Below 34,000: Sector Rotation in Canadian Markets
The TSX Composite Index falls below 34,000, driven by tech declines and sector rotation amidst risin…
Bank of Canada Meeting: What to Expect Amid Market Pressures
Market sentiment is clouded ahead of the Bank of Canada's meeting, with pressures from geopolitical …
Futures Slip as Geopolitical Jitters and Oil Prices Cloud Market Sentiment
Geopolitical tensions and rising oil prices are creating a cautious market atmosphere ahead of key e…
Sentiment Rebound: Is the Market Flashing a Contrarian Buy Signal?
A significant jump in market sentiment may indicate a contrarian buy opportunity, but caution is war…
Earnings Season Heats Up: Tesla, Boeing and the 86% Beat Rate
As earnings season gains momentum, Tesla and Boeing stand out with strong earnings expectations ahea…
Volume Surge: What High Trading Activity Signals for US and Canadian Markets
Elevated trading volumes across North American markets indicate strong investor engagement and marke…